Inhibition of SCF ubiquitin ligases by engineered ubiquitin variants that target the Cul1 binding site on the Skp1–F-box interface
Journal Article
·
· Proceedings of the National Academy of Sciences of the United States of America
- Univ. of Toronto, ON (Canada). Terrence Donnelly Center for Cellular and Biomolecular Research. Banting and Best Dept. of Medical Research. Dept. of Molecular Genetics
- Mount Sinai Hospital, Toronto, ON (Canada). Lunenfeld-Tanenbaum Research Inst.
- Cornell Univ., Argonne, IL (United States). Dept. of Chemistry and Chemical Biology
- Mount Sinai Hospital, Toronto, ON (Canada). Lunenfeld-Tanenbaum Research Inst.; Univ. of Montreal, QC (Canada). Inst. of Immunology and Cancer Research
- Mount Sinai Hospital, Toronto, ON (Canada). Lunenfeld-Tanenbaum Research Inst.; Univ. of Toronto, ON (Canada). Dept. of Molecular Genetics
Skp1–Cul1–F-box (SCF) E3 ligases play key roles in multiple cellular processes through ubiquitination and subsequent degradation of substrate proteins. Although Skp1 and Cul1 are invariant components of all SCF complexes, the 69 different human F-box proteins are variable substrate binding modules that determine specificity. SCF E3 ligases are activated in many cancers and inhibitors could have therapeutic potential. Here, we used phage display to develop specific ubiquitin-based inhibitors against two F-box proteins, Fbw7 and Fbw11. Unexpectedly, the ubiquitin variants bind at the interface of Skp1 and F-box proteins and inhibit ligase activity by preventing Cul1 binding to the same surface. Using structure-based design and phage display, we modified the initial inhibitors to generate broad-spectrum inhibitors that targeted many SCF ligases, or conversely, a highly specific inhibitor that discriminated between even the close homologs Fbw11 and Fbw1. We propose that most F-box proteins can be targeted by this approach for basic research and for potential cancer therapies.
- Research Organization:
- Univ. of Toronto, ON (Canada)
- Sponsoring Organization:
- Canadian Cancer Society Research Inst. (Canada); Canadian Inst. of Health Research (CIHR) (Canada); National Inst. of Health (NIH) (United States); USDOE Office of Science (SC), Basic Energy Sciences (BES) (SC-22)
- Contributing Organization:
- Cornell Univ., Argonne, IL (United States); Mount Sinai Hospital, Toronto, ON (Canada); Univ. of Montreal, QC (Canada)
- Grant/Contract Number:
- AC02-06CH11357
- OSTI ID:
- 1247362
- Journal Information:
- Proceedings of the National Academy of Sciences of the United States of America, Journal Name: Proceedings of the National Academy of Sciences of the United States of America Journal Issue: 13 Vol. 113; ISSN 0027-8424
- Publisher:
- National Academy of Sciences, Washington, DC (United States)Copyright Statement
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Structural Basis of Dimerization-dependent Ubiquitination by the SCFFbx4 Ubiquitin Ligase
Protein Kinase R Degradation Is Essential for Rift Valley Fever Virus Infection and Is Regulated by SKP1-CUL1-F-box (SCF)FBXW11-NSs E3 Ligase
Structural Basis of the Cks1-Dependent Recognition of P27Kip1 by the SCF skp2 Ubiquitin Ligase
Journal Article
·
Thu Dec 31 23:00:00 EST 2009
· Journal of Biological Chemistry
·
OSTI ID:1019681
Protein Kinase R Degradation Is Essential for Rift Valley Fever Virus Infection and Is Regulated by SKP1-CUL1-F-box (SCF)FBXW11-NSs E3 Ligase
Journal Article
·
Mon Feb 01 19:00:00 EST 2016
· PLoS Pathogens
·
OSTI ID:1378555
Structural Basis of the Cks1-Dependent Recognition of P27Kip1 by the SCF skp2 Ubiquitin Ligase
Journal Article
·
Fri Dec 31 23:00:00 EST 2004
· Mol. Cell
·
OSTI ID:913743